Literature DB >> 31280663

Evolution of Evidence and Guideline Recommendations for the Medical Management of Severe Traumatic Brain Injury.

Victor Volovici1,2, Ewout W Steyerberg2,3, Maryse C Cnossen2, Iain K Haitsma1, Clemens M F Dirven1, Andrew I R Maas4, Hester F Lingsma2.   

Abstract

Brain Trauma Foundation (BTF) Guidelines for medical management of severe traumatic brain injury (TBI) have become a global standard for the treatment of TBI patients. We aim to explore the evolution of the guidelines for the management of severe TBI. We reviewed the four editions of the BTF guidelines published over the past 20 years. The 1996 and 2000 editions were merged because of minimal differences, and are referred to as the 1996 edition. We described changes in topics and recommendations over time, and analyzed predictors of survival of recommendations with logistical regression. The guidelines contained 27 recommendations on 18 topics in 2016, 35 recommendations on 15 topics in 2007, and 22 recommendations on 10 topics in 1996. Substantial delays were found between the search for evidence and the guideline publication, ranging from 18 to 34 months. The overall body of evidence comprised 189 studies on 18 topics in 2016, compared with 156 studies on 15 topics in 2007 and 180 studies on 10 topics in 1996. Over time, a total of 175 studies were discarded from the evidence base following more rigorous grading of evidence. A total of 15/23 (65%) of the 1996/2000 recommendations were discarded over time. Out of 12 new recommendations introduced in the 2007 edition, 8 (66%) were discarded in 2016. Survival of recommendations varied between 33% and 100% for level I recommendations and between 11% and 31% for level II and III recommendations. No predictors of survival of recommendations were found. Substantial delays exist between literature search and publication, and survival rate of TBI guideline recommendations is poor. These factors may adversely affect currency and adherence to guidelines. The TBI community should take responsibility for improving the quality of the evidence base and ensuring that the translation of the evidence into guidelines supports clinicians in daily clinical practice.

Entities:  

Keywords:  BTF Guidelines; evidence base; guidelines for severe TBI; survival of recommendations

Year:  2019        PMID: 31280663     DOI: 10.1089/neu.2019.6474

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  11 in total

1.  MRI studies of traumatic axonal injury: still a long way to go-misuse of the Adams classification.

Authors:  Victor Volovici; Gavin F Bruggeman; Iain K Haitsma
Journal:  Acta Neurochir (Wien)       Date:  2021-02-13       Impact factor: 2.216

Review 2.  Considering Biological Sex in Traumatic Brain Injury.

Authors:  Anat Biegon
Journal:  Front Neurol       Date:  2021-02-10       Impact factor: 4.003

3.  The Clinical Differences of Patients With Traumatic Brain Injury in Plateau and Plain Areas.

Authors:  Yongxiang Yang; Yuping Peng; Siyi He; Jianping Wu; Qingyun Xie; Yuan Ma
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.003

4.  Comparative effectiveness of intracranial hypertension management guided by ventricular versus intraparenchymal pressure monitoring: a CENTER-TBI study.

Authors:  Victor Volovici; Dana Pisică; Benjamin Y Gravesteijn; Clemens M F Dirven; Ewout W Steyerberg; Ari Ercole; Nino Stocchetti; David Nelson; David K Menon; Giuseppe Citerio; Mathieu van der Jagt; Andrew I R Maas; Iain K Haitsma; Hester F Lingsma
Journal:  Acta Neurochir (Wien)       Date:  2022-06-01       Impact factor: 2.816

Review 5.  Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review.

Authors:  Magnolia Cardona; Louise Craig; Mark Jones; Oyungerel Byambasuren; Mila Obucina; Laetitia Hattingh; Justin Clark; Paul Glasziou; Tammy Hoffmann
Journal:  Glob Heart       Date:  2022-08-12

6.  Risk factors for corticosteroid insufficiency during the sub-acute phase of acute traumatic brain injury.

Authors:  Xin Chen; Yan Chai; Shao-Bo Wang; Jia-Chong Wang; Shu-Yuan Yue; Rong-Cai Jiang; Jian-Ning Zhang
Journal:  Neural Regen Res       Date:  2020-07       Impact factor: 5.135

7.  Functional outcome, in-hospital healthcare consumption and in-hospital costs for hospitalised traumatic brain injury patients: a Dutch prospective multicentre study.

Authors:  Jeroen T J M van Dijck; Cassidy Q B Mostert; Alexander P A Greeven; Erwin J O Kompanje; Wilco C Peul; Godard C W de Ruiter; Suzanne Polinder
Journal:  Acta Neurochir (Wien)       Date:  2020-05-14       Impact factor: 2.216

Review 8.  Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury.

Authors:  Alison E Willing; Mahasweta Das; Mark Howell; Shyam S Mohapatra; Subhra Mohapatra
Journal:  CNS Neurosci Ther       Date:  2020-03-10       Impact factor: 5.243

Review 9.  Traumatic axonal injury (TAI): definitions, pathophysiology and imaging-a narrative review.

Authors:  Gavin F Bruggeman; Iain K Haitsma; Clemens M F Dirven; Victor Volovici
Journal:  Acta Neurochir (Wien)       Date:  2020-10-02       Impact factor: 2.216

10.  Decompressive Craniectomy in Traumatic Brain Injury: An Institutional Experience of 131 Cases in Two Years.

Authors:  Ana Cristina Veiga Silva; Matheus Araújo de Oliveira Farias; Luiz Severo Bem; Marcelo Moraes Valença; Hildo Rocha Cirne de Azevedo Filho
Journal:  Neurotrauma Rep       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.